| Name | Title | Contact Details |
|---|---|---|
Robert Truckenmiller |
Chief Executive Officer | Profile |
Rob Macrae |
General Counsel, US Commercial, at GSK | Profile |
Sarah Clements |
Senior Vice President and Head of Legal - Group Transformation and Separation | Profile |
Michael Riordan |
Assistant General Counsel | Profile |
Jennean Endres |
Vice President Legal, US Respiratory, US Rx Contracting, Digital Channels and Operations | Profile |
Fleming Pharmaceuticals is a Fenton, MO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Milestone was founded in 2005 with the underlying concept to base its drug development programs on clinically validated mechanisms of action in order to mitigate as much drug development risk as possible. The company has raised a total of $34 million in venture capital financing since 2006. At its founding, the company assembled a panel of leading pharmaceutical R&D executives (“drug hunters”) each with an average of 30 years experience in drug development. The drug hunters proposed NCE projects based on clinically proven science to form the basis of Milestone’s drug development programs. Milestone has a seasoned management team with experience in cardiovascular diseases, drug development and business start-ups as well as world-class advisory boards of key opinion leaders with significant expertise in cardiology, regulatory affairs, as well as formulation and drug development.
Ipsen S.A. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Cylene Pharmaceuticals is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We are completely committed to the success of every one of our client-partners and dedicate ourselves to quality and efficiency. We provide custom formulation and quality manufacturing for your existing formulas and welcome the opportunity to provide